In this randomized , double-blind , parallel-group , single-center , proof-of-principle clinical trial , we tested the hypothesis that 23 sessions of active rTMS-DLPFC delivered over eight weeks would be feasible , safe and superior to sham rTMS to decrease the number of headache days in 18 patients with chronic migraine without severe depression .